Dr. Reza Khazaeizadeh, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 243 N Farmersville Blvd, Farmersville, CA 93223 Phone: 559-747-5200 |
Dr. James Erwin Stewart, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1122 North Matthew Ave, Farmersville, CA 93223 Phone: 559-747-3885 |
News Archive
A high level of a hormone that regulates phosphate is associated with an increased risk of kidney failure and death among chronic kidney disease (CKD) patients, according to a recent study led by researchers at the University of Miami and funded by the National Institute of Diabetes and Digestive Diseases and Kidney Diseases (NIDDK) at the National Institutes of Health.
As Mayor Michael Bloomberg's term comes to a close, the latest research conducted by Columbia University's Mailman School of Public indicates that he leaves a legacy of ambitious public health policies from pioneering restrictions on trans fats and smoking to investments in green spaces and bicycle lanes that have improved the health and increased the life expectancy of New Yorkers. The paper takes a behind-the-scenes look at the Bloomberg Administration to evaluate the evidence and build public support for improving health in the city-which also can serve as a blueprint for health policy in cities across the country.
Genome researchers from Bielefeld University's Center for Biotechnology (CeBiTec) headed by Professor Dr. Alfred P-hler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster supplies the cell cultures used by the pharmaceutical industry to produce biopharmaceutical products such as antibodies used in medicine.
Aetna (NYSE:ΑET) announced today that beginning January 1, 2010, its Medicare Advantage members will have access to MidState Medical Center and Windham Hospital as part of Aetna's Medicare network of participating health care facilities in Connecticut.
AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical trial of ARX-03, a proprietary sublingual dosage form combining an opioid, sufentanil, with a benzodiazepine, triazolam.
› Verified 8 days ago